The Novel Plk Inhibitor Volasertib Overcomes Cytarabine Resistance in Acute Myeloid Leukemia

被引：0
|
作者：
Fu, Shuang [1 ]
Kelly, Kevin R. [2 ]
Espitia, Claudia M. [3 ]
Han, Yingchun [1 ]
Carraway, Hetty E. [4 ]
Advani, Anjali S. [4 ]
Maciejewski, Jaroslaw P. [4 ]
Sekeres, Mikkael A. [4 ]
Steffan, Nawrocki T. [3 ]
Carew, Jennifer S. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[2] Univ So Calif, Los Angeles, CA USA
[3] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[4] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Posttranslational splicing modifications as a key mechanism in cytarabine resistance in acute myeloid leukemia
    María Luz Morales
    Roberto García-Vicente
    Alba Rodríguez-García
    Armando Reyes-Palomares
    África Vincelle-Nieto
    Noemí Álvarez
    Alejandra Ortiz-Ruiz
    Vanesa Garrido-García
    Alicia Giménez
    Gonzalo Carreño-Tarragona
    Ricardo Sánchez
    Rosa Ayala
    Joaquín Martínez-López
    María Linares
    Leukemia, 2023, 37 : 1649 - 1659
  • [32] A Novel Role for PLK1 in Leukemia Stem Cell Function in Acute Myeloid Leukemia
    Liu, Qiang
    Murison, Alex
    Zeng, Andy G. X.
    Xu, Changjiang
    Voisin, Veronique
    Yeung, Faith
    Subedi, Amit
    Chan, Steven M.
    Raught, Brian
    Bader, Gary D.
    Dick, John E.
    Wang, Jean C. Y.
    BLOOD, 2022, 140 : 5920 - 5921
  • [33] Cytarabine and skin reactions in acute myeloid leukemia
    Grille, Sofia
    Guadagna, Regina
    Boada, Matilde
    Irigoin, Victoria
    Stevenazzi, Mariana
    Guillermo, Cecilia
    Diaz, Lilian
    MEDICINA-BUENOS AIRES, 2013, 73 (06) : 535 - 538
  • [34] Cytarabine Dose for Acute Myeloid Leukemia REPLY
    Lowenberg, Bob
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2168 - 2169
  • [35] Targeting CCL2/CCR2 Signaling Overcomes MEK Inhibitor Resistance in Acute Myeloid Leukemia
    Modak, Rucha V.
    Rebola, Katia G. de Oliveira
    McClatchy, John
    Mohammadhosseini, Mona
    Damnernsawad, Alisa
    Kurtz, Stephen E.
    Eide, Christopher A.
    Wu, Guanming
    Laderas, Ted
    Nechiporuk, Tamilla
    Gritsenko, Marina A.
    Hansen, Joshua R.
    Hutchinson, Chelsea
    Gosline, Sara J. C.
    Piehowski, Paul
    Bottomly, Daniel
    Short, Nicholas
    Rodland, Karin
    McWeeney, Shannon K.
    Tyner, Jeffrey W.
    Agarwal, Anupriya
    CLINICAL CANCER RESEARCH, 2024, 30 (10) : 2245 - 2259
  • [36] Ceramide-induced integrated stress response overcomes Bcl-2 inhibitor resistance in acute myeloid leukemia
    Lewis, Alexander C.
    Pope, Victoria S.
    Tea, Melinda N.
    Li, Manjun
    Nwosu, Gus O.
    Nguyen, Thao M.
    Wallington-Beddoe, Craig T.
    Moretti, Paul A. B.
    Anderson, Dovile
    Creek, Darren J.
    Costabile, Maurizio
    Ali, Saira R.
    Thompson-Peach, Chloe A. L.
    Dredge, B. Kate
    Bert, Andrew G.
    Goodall, Gregory J.
    Ekert, Paul G.
    Brown, Anna L.
    D'Andrea, Richard
    Robinson, Nirmal
    Pitman, Melissa R.
    Thomas, Daniel
    Ross, David M.
    Gliddon, Briony L.
    Powell, Jason A.
    Pitson, Stuart M.
    BLOOD, 2022, 139 (26) : 3737 - 3751
  • [37] Cytarabine and daunorubicin for the treatment of acute myeloid leukemia
    Murphy, Tracy
    Yee, Karen W. L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1765 - 1780
  • [38] The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
    Alessandro Di Tullio
    Kevin Rouault-Pierre
    Ander Abarrategi
    Syed Mian
    William Grey
    John Gribben
    Aengus Stewart
    Elizabeth Blackwood
    Dominique Bonnet
    Nature Communications, 8
  • [39] The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia
    Di Tullio, Alessandro
    Rouault-Pierre, Kevin
    Abarrategi, Ander
    Mian, Syed
    Grey, William
    Gribben, John
    Stewart, Aengus
    Blackwood, Elizabeth
    Bonnet, Dominique
    NATURE COMMUNICATIONS, 2017, 8
  • [40] Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies
    Zhai, Yifan
    Tang, Qiuqiong
    Fang, Douglas D.
    Deng, Jing
    Zhang, Kaixiang
    Wang, Qixin
    Yin, Yan
    Fu, Chengcheng
    Xue, Sheng -Li
    Li, Na
    Zhou, Feng
    Yang, Dajun
    CLINICAL CANCER RESEARCH, 2023, 29 (01) : 183 - 196
12345